CVS · 10-Q · 2026Q2 · Full report

340B Program Uncertainty

CVS HEALTH Corp · 2026-08-05 · Importance 23 · Surprise 24

The federal 340B drug pricing program remains a dynamic regulatory environment. CVS Health stated that developments in the program may continue to affect its Health Services segment, which provides administrative, management and reporting services to 340B Covered Entities. The filing does not identify a specific rule, jurisdictional change or quantified financial exposure.

Key facts